Design and rationale of DemonsTTRate: a global, long-term observational study to evaluate vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy

10 May 2026 (08:30 - 09:15)
Organised by: Logo
Congress Presentation Part of: Evolving management of cardiomyopathies: early detection, precision diagnostics, and emerging treatments Trial Design Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by